Outcomes of systemic targeted therapy in recurrent renal cell carcinoma treated with adjuvant sunitinib.
de Velasco G, Ruiz-Granados Á, Reig O, Massari F, Climent Duran MA, Verzoni E, Graham J, Llarena R, De Tursi M, Donskov F, Iglesias C, Pandha HS, Garcia Del Muro X, Procopio G, Oudard S, Castellano D, Albiges L.
de Velasco G, et al. Among authors: llarena r.
BJU Int. 2021 Aug;128(2):254-261. doi: 10.1111/bju.15356. Epub 2021 Apr 19.
BJU Int. 2021.
PMID: 33547860